Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03906253 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor 2 versions Re-verified since Mar 24, 2025, no change to tracked fieldsv10-v11
  2. Notable Primary and study completion dates: Dec 2027 to Dec 2028v9
  3. Minor Re-verified, no change to tracked fieldsv8
  4. Notable Primary and study completion dates: Dec 2025 to Dec 2027
    • Trial status: Enrolling by Invitation to Recruiting
    • Site details revised
    v7
  5. Notable Lead sponsor: Jeffrey B. Travers, MD, PhD to Wright State Universityv6
Show 4 earlier versionsHide 4 earlier versions
  1. Minor Re-verified, no change to tracked fieldsv5
  2. Minor Trial status: Recruiting to Enrolling by Invitation
    • Site details revised
    v4
  3. Minor Study arms: 1 to 2v3
  4. Notable Primary endpoints revised (2)v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is following up on previous studies that have demonstrated that geriatric subjects respond different to ultraviolet B (UVB) light than young subjects. The treatment of geriatric skin with dermal rejuvenation therapies (dermabrasion, fractionated laser resurfacing) restores the appropriate UVB response. Ongoing studies have tested the ability of fractionated laser resurfacing (FLR) to assess how long this wounding effect lasts-and have found that this appears to be a durable response which lasts for at least two years. The findings that FLR protects geriatric skin at two years is the impetus for this study. This study is an interventional study to assess if FLR treatment of one forearm of geriatric subjects with multiple actinic keratosis will result in the short-term removal of actinic keratosis, and the long-term decrease in levels of future actinic keratosis and other non-melanoma skin cancers in comparison to the untreated arm. Study length and visit: The first part of the study is completed in 1 day then there are follow up visits at 90 days and every 6 months for 5 years.
Trial Details
NCT Number NCT03906253
Lead Sponsor Wright State University
Conditions
(from sponsor)
Actinic Keratoses, Aging, Non-Melanoma Skin Cancer
Related terms Keratosis, Actinic
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov